CD8A and COVID-19: Two independent research groups observed that SARS-CoV-2 memory B cells, CD8+ T cells, and CD4+ T cells remained measurable for more than 6 months after infection, whereas antibodies against SARS-CoV-2 spike and RBD waned gradually 8 months after COVID-19 onset [17,19].